Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target.

Source:http://linkedlifedata.com/resource/pubmed/id/17483313

Cancer Res. 2007 May 1 67 9 4028-33

Download in:

View as

General Info

PMID
17483313